Product Information
TEMOZOLOMIDE 20 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.8798 per EA under NDC 47335089172. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335089172
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742FDA Approved
2/12/2014
TE Code
AB
On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 20 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 81.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8798 per EA |
|---|---|
| All-time high | $4.8083 (Feb 12, 2025) |
| All-time low | $0.8798 (Jul 22, 2026) |
| 52-week high | $4.1124 |
| 52-week low | $0.8798 |
| Median price | $4.1124 |
| Average price | $3.7933 |
| Largest weekly change | -48.7% (Feb 18, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 20 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.8798 per EA (NDC 47335089172), effective Aug 19, 2026.
How has the price of TEMOZOLOMIDE 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 20 MG CAPSULE has declined 81.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 20 MG CAPSULE?
Since Apr 17, 2024, the NADAC for TEMOZOLOMIDE 20 MG CAPSULE has ranged from a low of $0.8798 (Jul 22, 2026) to a high of $4.8083 (Feb 12, 2025), with a median of $4.1124 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 20 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMOZOLOMIDE 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 20 MG CAPSULE?
TEMOZOLOMIDE 20 MG CAPSULE (NDC 47335089172) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.